
Moderna’s COVID-19 vaccine may have some slight advantages over the Pfizer shot, new research suggests. For the study, researchers tracked antibody levels in 234 people for 10 months after they received either the two-dose Pfizer (114 people) or Moderna (114 people) mRNA vaccines, or the single-dose Johnson & Johnson (6 people) shot, which uses a… read on > read on >